Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of blood coagulation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of blood coagulation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | ||
| VEGFA | vascular endothelial growth factor A | 0.999 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.999 | Human | |
| C1QA | complement component 1, q subcomponent, A chain | 0.998 | Human | |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.994 | ||
| NRP1 | neuropilin 1 | 0.980 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.956 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.942 | Human | |
| ALB | albumin | 0.918 | ||
| PLAU | plasminogen activator, urokinase | 0.869 | Human Mouse | |
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.862 | ||
| FGA | fibrinogen alpha chain | 0.850 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.846 | Human | |
| C1R | complement component 1, r subcomponent | 0.717 | ||
| HP | haptoglobin | 0.704 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.640 | ||
| PGF | placental growth factor | 0.629 | Human | |
| PLG | plasminogen | 0.608 | ||
| S100A10 | S100 calcium binding protein A10 | 0.605 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.583 | ||
| EGFR | epidermal growth factor receptor | 0.576 | ||
| KNG1 | kininogen 1 | 0.572 | ||
| PCYT2 | phosphate cytidylyltransferase 2, ethanolamine | 0.543 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.534 | Human | |
| SYK | spleen tyrosine kinase | 0.505 | ||
| PLAT | plasminogen activator, tissue | 0.498 | Human | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.416 | ||
| FGB | fibrinogen beta chain | 0.410 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.372 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.366 | Human | |
| PDGFC | platelet derived growth factor C | 0.348 | ||
| APOC1 | apolipoprotein C-I | 0.307 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.277 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.250 | ||
| A2M | alpha-2-macroglobulin | 0.247 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.238 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.214 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.173 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.169 | ||
| F11 | coagulation factor XI | 0.169 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.158 | ||
| HRG | histidine-rich glycoprotein | 0.151 | Mouse | |
| CDCP1 | CUB domain containing protein 1 | 0.143 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.142 | ||
| AXL | AXL receptor tyrosine kinase | 0.139 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.135 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.127 | ||
| APOA2 | apolipoprotein A-II | 0.126 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.121 | ||
| F2 | coagulation factor II (thrombin) | 0.112 | ||
| C3 | complement component 3 | 0.107 | ||
| MAPT | microtubule-associated protein tau | 0.105 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.102 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.100 | ||
| APOC3 | apolipoprotein C-III | 0.092 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.090 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.088 | ||
| LDLR | low density lipoprotein receptor | 0.085 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.084 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.080 | Human | |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.076 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.074 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.072 | ||
| C8A | complement component 8, alpha polypeptide | 0.069 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.067 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.067 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.067 | ||
| LAT | linker for activation of T cells | 0.067 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.066 | ||
| FN1 | fibronectin 1 | 0.063 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.056 | ||
| MSN | moesin | 0.053 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.052 | ||
| ANXA1 | annexin A1 | 0.051 | ||
| BGN | biglycan | 0.049 | ||
| F10 | coagulation factor X | 0.049 | Human | |
| FGFR1 | fibroblast growth factor receptor 1 | 0.047 | ||
| C8B | complement component 8, beta polypeptide | 0.047 | ||
| STAB1 | stabilin 1 | 0.046 | ||
| VWF | von Willebrand factor | 0.046 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.045 | ||
| LPA | lipoprotein, Lp(a) | 0.044 | Human | |
| TEK | TEK tyrosine kinase, endothelial | 0.044 | ||
| VTN | vitronectin | 0.042 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.041 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.041 | ||
| S100A11 | S100 calcium binding protein A11 | 0.037 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.035 | ||
| ENG | endoglin | 0.035 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.034 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.034 | ||
| PRKCB | protein kinase C, beta | 0.033 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.033 | ||
| KITLG | KIT ligand | 0.033 | ||
| PLTP | phospholipid transfer protein | 0.032 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.031 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.031 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.030 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.030 | Human | |
| ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.030 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.028 | ||
| PTEN | phosphatase and tensin homolog | 0.028 | ||
| NNMT | nicotinamide N-methyltransferase | 0.028 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.028 | ||
| DCN | decorin | 0.028 | ||
| C6 | complement component 6 | 0.027 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.027 | ||
| APOC4 | apolipoprotein C-IV | 0.027 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.027 | ||
| APOA1 | apolipoprotein A-I | 0.026 | Human | |
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.025 | ||
| CD63 | CD63 molecule | 0.025 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.025 | ||
| GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0.025 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.024 | ||
| VEGFC | vascular endothelial growth factor C | 0.024 | Human | |
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.024 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.024 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.023 | Human | |
| APOC2 | apolipoprotein C-II | 0.023 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.023 | ||
| CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.022 | ||
| FGG | fibrinogen gamma chain | 0.022 | ||
| TUBB6 | tubulin, beta 6 | 0.022 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.022 | ||
| CHRD | chordin | 0.021 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.021 | ||
| ORM1 | orosomucoid 1 | 0.021 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.021 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.021 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.020 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.020 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.020 | ||
| MARCO | macrophage receptor with collagenous structure | 0.019 | ||
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.019 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.019 | ||
| OSMR | oncostatin M receptor | 0.019 | ||
| HPN | hepsin | 0.018 | ||
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.018 | ||
| STC1 | stanniocalcin 1 | 0.018 | ||
| ARRDC3 | arrestin domain containing 3 | 0.018 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.018 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.018 | ||
| DPYS | dihydropyrimidinase | 0.018 | ||
| C1S | complement component 1, s subcomponent | 0.018 | ||
| LIPC | lipase, hepatic | 0.018 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.018 | ||
| SERPINA7 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 | 0.018 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.018 | Human | |
| C2 | complement component 2 | 0.018 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.017 | ||
| HPX | hemopexin | 0.017 | ||
| AFM | afamin | 0.017 | ||
| ANGPTL3 | angiopoietin-like 3 | 0.017 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.017 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.017 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.017 | ||
| VIM | vimentin | 0.016 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.016 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.016 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.016 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.016 | ||
| SERPINF1 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 | 0.016 | Human | |
| TRIM9 | tripartite motif containing 9 | 0.016 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.016 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.016 | ||
| SPHK1 | sphingosine kinase 1 | 0.016 | ||
| AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.016 | ||
| GP1BA | glycoprotein Ib (platelet), alpha polypeptide | 0.015 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.015 | ||
| CPN2 | carboxypeptidase N, polypeptide 2 | 0.015 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.015 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.015 | ||
| APCS | amyloid P component, serum | 0.015 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.015 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.015 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.015 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.015 | ||
| SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.015 | Human | |
| HGFAC | HGF activator | 0.015 | Human | |
| ARG1 | arginase, liver | 0.015 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.014 | ||
| F13B | coagulation factor XIII, B polypeptide | 0.014 | ||
| ITIH4 | inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein) | 0.014 | ||
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.014 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.014 | ||
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.014 | Human Mouse | |
| CYP2A7 | cytochrome P450, family 2, subfamily A, polypeptide 7 | 0.014 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.014 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.014 | ||
| FETUB | fetuin B | 0.013 | ||
| EMP3 | epithelial membrane protein 3 | 0.013 | ||
| OLFML2B | olfactomedin-like 2B | 0.013 | ||
| PKLR | pyruvate kinase, liver and RBC | 0.013 | ||
| CAV2 | caveolin 2 | 0.013 | ||
| MRC1 | mannose receptor, C type 1 | 0.013 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.013 | ||
| AGXT | alanine-glyoxylate aminotransferase | 0.013 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.013 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.013 | ||
| UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | 0.013 | ||
| F9 | coagulation factor IX | 0.013 | Human | |
| NRP2 | neuropilin 2 | 0.012 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.012 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.012 | Rat | |
| STAB2 | stabilin 2 | 0.012 | ||
| PON3 | paraoxonase 3 | 0.012 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.012 | ||
| CD93 | CD93 molecule | 0.012 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.012 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.012 | ||
| TMEM176B | transmembrane protein 176B | 0.012 | ||
| RCN3 | reticulocalbin 3, EF-hand calcium binding domain | 0.012 | ||
| INHBA | inhibin, beta A | 0.012 | ||
| EMP1 | epithelial membrane protein 1 | 0.012 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.012 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.012 | ||
| CFHR4 | complement factor H-related 4 | 0.012 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.011 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.011 | ||
| TPM4 | tropomyosin 4 | 0.011 | ||
| CRP | C-reactive protein, pentraxin-related | 0.011 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.011 | ||
| IL32 | interleukin 32 | 0.011 | ||
| CFHR2 | complement factor H-related 2 | 0.011 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.011 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.011 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.011 | ||
| HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase | 0.011 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.011 | ||
| KLKB1 | kallikrein B, plasma (Fletcher factor) 1 | 0.011 | ||
| KRT5 | keratin 5 | 0.011 | ||
| IGFBP1 | insulin-like growth factor binding protein 1 | 0.011 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.011 | ||
| TMEM176A | transmembrane protein 176A | 0.010 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.010 | ||
| NID1 | nidogen 1 | 0.010 | ||
| AMT | aminomethyltransferase | 0.010 | ||
| APOF | apolipoprotein F | 0.010 | ||
| MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.010 | ||
| CRHBP | corticotropin releasing hormone binding protein | 0.010 | ||
| CD248 | CD248 molecule, endosialin | 0.010 | ||
| CFH | complement factor H | 0.010 | ||
| CA5A | carbonic anhydrase VA, mitochondrial | 0.010 | ||
| IGFBP7 | insulin-like growth factor binding protein 7 | 0.010 | ||
| DAO | D-amino-acid oxidase | 0.010 |